The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global AI for Cancer Diagnosis Market Research Report 2025
Synopsis
Global AI for Cancer Diagnosis market is projected to reach US$ 979.2 million in 2029, increasing from US$ 132.5 million in 2022, with the CAGR of 33.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI for Cancer Diagnosis market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI for Cancer Diagnosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Lunit Inc
Xilis
Shukun Technology
Kheiron
SkinVision
Infervision
Imagene AI
Oncora Medical
Niramai Health Analytix
Enlitic
Maxwell Plus
Therapixel
Ibex
OrigiMed
Tencent
Segment by Type
Breast Cancer
Lung Cancer
Prostatic Cancer
Others
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI for Cancer Diagnosis report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global AI for Cancer Diagnosis market is projected to reach US$ 979.2 million in 2029, increasing from US$ 132.5 million in 2022, with the CAGR of 33.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI for Cancer Diagnosis market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI for Cancer Diagnosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Lunit Inc
Xilis
Shukun Technology
Kheiron
SkinVision
Infervision
Imagene AI
Oncora Medical
Niramai Health Analytix
Enlitic
Maxwell Plus
Therapixel
Ibex
OrigiMed
Tencent
Segment by Type
Breast Cancer
Lung Cancer
Prostatic Cancer
Others
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI for Cancer Diagnosis report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI for Cancer Diagnosis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Breast Cancer
1.2.3 Lung Cancer
1.2.4 Prostatic Cancer
1.2.5 Others
1.3 Market by Application
1.3.1 Global AI for Cancer Diagnosis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI for Cancer Diagnosis Market Perspective (2018-2029)
2.2 AI for Cancer Diagnosis Growth Trends by Region
2.2.1 Global AI for Cancer Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 AI for Cancer Diagnosis Historic Market Size by Region (2018-2023)
2.2.3 AI for Cancer Diagnosis Forecasted Market Size by Region (2024-2029)
2.3 AI for Cancer Diagnosis Market Dynamics
2.3.1 AI for Cancer Diagnosis Industry Trends
2.3.2 AI for Cancer Diagnosis Market Drivers
2.3.3 AI for Cancer Diagnosis Market Challenges
2.3.4 AI for Cancer Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI for Cancer Diagnosis Players by Revenue
3.1.1 Global Top AI for Cancer Diagnosis Players by Revenue (2018-2023)
3.1.2 Global AI for Cancer Diagnosis Revenue Market Share by Players (2018-2023)
3.2 Global AI for Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI for Cancer Diagnosis Revenue
3.4 Global AI for Cancer Diagnosis Market Concentration Ratio
3.4.1 Global AI for Cancer Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI for Cancer Diagnosis Revenue in 2022
3.5 AI for Cancer Diagnosis Key Players Head office and Area Served
3.6 Key Players AI for Cancer Diagnosis Product Solution and Service
3.7 Date of Enter into AI for Cancer Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI for Cancer Diagnosis Breakdown Data by Type
4.1 Global AI for Cancer Diagnosis Historic Market Size by Type (2018-2023)
4.2 Global AI for Cancer Diagnosis Forecasted Market Size by Type (2024-2029)
5 AI for Cancer Diagnosis Breakdown Data by Application
5.1 Global AI for Cancer Diagnosis Historic Market Size by Application (2018-2023)
5.2 Global AI for Cancer Diagnosis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America AI for Cancer Diagnosis Market Size (2018-2029)
6.2 North America AI for Cancer Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America AI for Cancer Diagnosis Market Size by Country (2018-2023)
6.4 North America AI for Cancer Diagnosis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI for Cancer Diagnosis Market Size (2018-2029)
7.2 Europe AI for Cancer Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe AI for Cancer Diagnosis Market Size by Country (2018-2023)
7.4 Europe AI for Cancer Diagnosis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI for Cancer Diagnosis Market Size (2018-2029)
8.2 Asia-Pacific AI for Cancer Diagnosis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific AI for Cancer Diagnosis Market Size by Region (2018-2023)
8.4 Asia-Pacific AI for Cancer Diagnosis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI for Cancer Diagnosis Market Size (2018-2029)
9.2 Latin America AI for Cancer Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America AI for Cancer Diagnosis Market Size by Country (2018-2023)
9.4 Latin America AI for Cancer Diagnosis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI for Cancer Diagnosis Market Size (2018-2029)
10.2 Middle East & Africa AI for Cancer Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa AI for Cancer Diagnosis Market Size by Country (2018-2023)
10.4 Middle East & Africa AI for Cancer Diagnosis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lunit Inc
11.1.1 Lunit Inc Company Detail
11.1.2 Lunit Inc Business Overview
11.1.3 Lunit Inc AI for Cancer Diagnosis Introduction
11.1.4 Lunit Inc Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.1.5 Lunit Inc Recent Development
11.2 Xilis
11.2.1 Xilis Company Detail
11.2.2 Xilis Business Overview
11.2.3 Xilis AI for Cancer Diagnosis Introduction
11.2.4 Xilis Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.2.5 Xilis Recent Development
11.3 Shukun Technology
11.3.1 Shukun Technology Company Detail
11.3.2 Shukun Technology Business Overview
11.3.3 Shukun Technology AI for Cancer Diagnosis Introduction
11.3.4 Shukun Technology Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.3.5 Shukun Technology Recent Development
11.4 Kheiron
11.4.1 Kheiron Company Detail
11.4.2 Kheiron Business Overview
11.4.3 Kheiron AI for Cancer Diagnosis Introduction
11.4.4 Kheiron Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.4.5 Kheiron Recent Development
11.5 SkinVision
11.5.1 SkinVision Company Detail
11.5.2 SkinVision Business Overview
11.5.3 SkinVision AI for Cancer Diagnosis Introduction
11.5.4 SkinVision Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.5.5 SkinVision Recent Development
11.6 Infervision
11.6.1 Infervision Company Detail
11.6.2 Infervision Business Overview
11.6.3 Infervision AI for Cancer Diagnosis Introduction
11.6.4 Infervision Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.6.5 Infervision Recent Development
11.7 Imagene AI
11.7.1 Imagene AI Company Detail
11.7.2 Imagene AI Business Overview
11.7.3 Imagene AI AI for Cancer Diagnosis Introduction
11.7.4 Imagene AI Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.7.5 Imagene AI Recent Development
11.8 Oncora Medical
11.8.1 Oncora Medical Company Detail
11.8.2 Oncora Medical Business Overview
11.8.3 Oncora Medical AI for Cancer Diagnosis Introduction
11.8.4 Oncora Medical Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.8.5 Oncora Medical Recent Development
11.9 Niramai Health Analytix
11.9.1 Niramai Health Analytix Company Detail
11.9.2 Niramai Health Analytix Business Overview
11.9.3 Niramai Health Analytix AI for Cancer Diagnosis Introduction
11.9.4 Niramai Health Analytix Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.9.5 Niramai Health Analytix Recent Development
11.10 Enlitic
11.10.1 Enlitic Company Detail
11.10.2 Enlitic Business Overview
11.10.3 Enlitic AI for Cancer Diagnosis Introduction
11.10.4 Enlitic Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.10.5 Enlitic Recent Development
11.11 Maxwell Plus
11.11.1 Maxwell Plus Company Detail
11.11.2 Maxwell Plus Business Overview
11.11.3 Maxwell Plus AI for Cancer Diagnosis Introduction
11.11.4 Maxwell Plus Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.11.5 Maxwell Plus Recent Development
11.12 Therapixel
11.12.1 Therapixel Company Detail
11.12.2 Therapixel Business Overview
11.12.3 Therapixel AI for Cancer Diagnosis Introduction
11.12.4 Therapixel Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.12.5 Therapixel Recent Development
11.13 Ibex
11.13.1 Ibex Company Detail
11.13.2 Ibex Business Overview
11.13.3 Ibex AI for Cancer Diagnosis Introduction
11.13.4 Ibex Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.13.5 Ibex Recent Development
11.14 OrigiMed
11.14.1 OrigiMed Company Detail
11.14.2 OrigiMed Business Overview
11.14.3 OrigiMed AI for Cancer Diagnosis Introduction
11.14.4 OrigiMed Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.14.5 OrigiMed Recent Development
11.15 Tencent
11.15.1 Tencent Company Detail
11.15.2 Tencent Business Overview
11.15.3 Tencent AI for Cancer Diagnosis Introduction
11.15.4 Tencent Revenue in AI for Cancer Diagnosis Business (2018-2023)
11.15.5 Tencent Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
